Transactions in a Closed Period

RNS Number : 1868G
Polar Capital Global Health Tst PLC
15 November 2022
 

Polar Capital Global Healthcare Trust plc ("the Company")

 

Legal Entity Identifier: 549300YV7J2TWLE7PV84

 

 

15 November 2022

 

 

Transactions in a Closed Period

The Company confirms that:

 

·     all inside information (as defined in the Market Abuse Regulation) which the Directors and the Company may have, in the period leading up to the announcement of results in respect of the year ended 30 September 2022 has previously been published or notified via a regulatory information service; and

 

· the Company's net asset value per share is calculated and announced via a regulatory information service daily.

 

The Company is therefore not prohibited from dealing in its own securities during the closed period, (as defined by the Market Abuse Regulation) which will end on expected publication of the Company's annual results on or around 15 December 2022.

 

The Company further confirms that:

 

if, in the period leading up to the announcement of the annual results, the Directors of the Company come into possession of any inside information, this will be notified to a regulatory information service before any such dealings are undertaken. 

 

For further information, please contact:

 

Tracey Lago, FCG

Director

Polar Capital Secretarial Services

Corporate Secretary

 

 

 

 

+44 (0)20 7227 2700

 

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
MSCUASORUUUAAAA
UK 100

Latest directors dealings